Prevalence of Multidrug Resistance in Streptococcus Pyogenes Isolates from Different Clinical Sources in Al-Diwaniyah City

  • Huda Refaat Ibraheem Department of Biology, College of Science, University of Al-Qadisiyah, Al- Diwaniayh , Iraq
  • Ghaidaa Jihadi Mohammed Department of Biology, College of Science, University of Al-Qadisiyah, Al- Diwaniayh , Iraq
Keywords: Multidrug resistance, S. pyogenes, Pharyngitis

Abstract

Background: Streptococcus pyogenes also known as group A Streptococci (GAS) is an important pathogen for human that causes a wide variety of diseases. Despite the fact that antibiotics are effective to treat GAS infections, antibiotic resistance particularly to macrolides is increasing in a number of countries causes an increase in mortality, which has become a global public health concern.

Aim: Determine the prevalence of multidrug resistance in Streptococcus pyogenes isolates from different clinical sources in Al-Diwaniyah city.

Method : The study included the collection of (125) samples from different clinical source(Throat swabs, tonsils, urine ,burns) from patients in Al-Diwaniyah teaching hospital and Burns' hospital in Al-Diwaniyah city, during the period from 15-8-2022 to 1-12-2023 .The patients were with different ages ranging from 6-50 years, and from both sexes. The identification of bacterial isolates were achieved by morphological characteristics of bacterial colonies on selective media , result of Bacitracin sensitivity test ,Gram stain, and biochemical tests and confirmed the diagnosis by Vitek system.

Results : A total of 20 (16.0%) isolates were identified as S.pyogenes from (125) clinical samples that collected from different sources, that distributed by 1 (5.0% )from Throat Swab ,and 19 (95.0%) from Tonsils samples , and No isolate detected from urine and burns samples . The results of antibiotic sensitivity test showed all isolates were sensitive to Ciprofloxacin and Vancomycin, on the other hand, 1(5.0%), 1(5.0%), 3(14.0%), 2(9.0%), 4(18.0%), 5(23.0%), 15(68.0%), 21(95.0%) isolates were resistance for Azithromycin, Clarithromycin, Erythromycin, Clindamycin, Levofloxacin, Chloramphenicol, Tetracycline, Penicillin, Oxacillin, respectively. Based on the multidrug-resistance (MDR) profile, a total of 3 out of 22 (14.0%) Streptococcus pyogenes isolates were resistant to 3 or more of antibiotics.

Conclusion : This study revealed that Streptococcus pyogenes mostly isolated from tonsils. Isolates showed high levels of resistance to most of the commercially available antibiotics. A high percentage of MDR among commonly isolated bacteria were found in this study would be a serious, alarming issue.

References

1. Kimberlin, D.W.; Brady, M.T.; Jackson, M.A.(2015) Group A Streptococcal Infections; American Academy of Pediatrics: Itasca, IL, USA, pp. 732–744.
2. Walker, M. J.; Barnett, T. C.; McArthur, J. D.; Cole, J. N.; Gillen,C.M.; Henningham, A. (2014). Disease manifestations and pathogenic mechanisms of group A streptococcus. J Clinical Microbiology. 27 (2). pp: 264-301
3. Abbas, A. and Wida, Q.H., (2021). Isolation and Identification of Streptococcus pyogenes from Patients and Objects in Hospital Environment in Thi-Qarcity in Iraq. Indian Journal of Forensic Medicine & Toxicology, 15(4).
4. Soderholm AT, Barnett TC, Sweet MJ, Walker MJ. (2017). Group A streptococcal pharyngitis: immune responses involved in bacterial clearance and GAS-associated immunopathologies. J Leukoc Biol doi:10.1189/jlb.4MR0617-227RR.
5. Soderholm, A., (2018). The Group A Streptococcus M1 T1 clone post-transcriptionally modifies innate immune signaling to promote infection. Doctor of Philosophy. The University of Queensland. Australia.
6. Lu, B., Fang, Y., Fan, Y., Chen, X., Wang, J., Zeng, J., Li, Y., Zhang, Z., Huang, L., Li, H. and Li, D., (2017). High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016. Frontiers in microbiology, 8, p.1052.
7. Bhardwaj, N.; Mathur, P.; Behera, B.; Mathur, K.; Kapil, A. and Misra, M. C. (2018). Antimicrobial resistance in beta-haemolytic streptococci in India: a four-year study. Indian J. Med. Res. 147, 81–87. doi: 10.4103/ijmr.IJMR_1517_16.
8. Wajima, T., Chiba, N., Morozumi, M., Shouji, M., Sunaoshi, K., Sugita, K., Tajima, T., Ubukata, K. and GAS Surveillance Study Group, (2014). Prevalence of macrolide resistance among group A streptococci isolated from pharyngotonsillitis. Microbial Drug Resistance, 20(5), pp.431-435.
9. Silva-Costa, C.; Friães, A.; Ramirez, M., and Melo-Cristino, J. (2015). Macrolideresistant Streptococcus pyogenes: prevalence and treatment strategies. Expert Rev. Anti Infect. Ther. 13,615-628.doi;10.1586-14787210.2015.1023292.
10. Muthanna A., Salim H.S., Hamat R. A., Shamsuddin N.H. and Zakariah, S. Z., (2018). Clinical Screening Tools to Diagnose Group A Streptococcal Pharyngo-tonsillitis in Primary Care Clinics to Improve Prescribing Habits. Malays J Med Sci. 25(6): 6–21.
11. Ferretti J., Stevens D. and Fischetti V. (2016). Streptococcus pyogenes Basic Biology to Clinical Manifestations, editer book, University of Oklahoma Health Sciences Center.1050 page.
12. Singla, V., Mandal, S., Sharma, P., Anand, S. and Tomar, S.K., 2018. Antibiotic susceptibility profile of Pediococcus spp. from diverse sources. 3 Biotech, 8, pp.1-17.
13. Mahdi, A.Z., Hassan, J.H. and Jebur, K.S., (2017). Antibiotic Susceptibility of Streptococcus pyogenes Isolated from Otitis Media and Tonsilitis among Children Patients. Int. J. Curr. Microbiol. App. Sci, 6(8), pp.998-1004.
14. Ingale M.H. and Mahajan G.D. (2018). Evaluation of antibiotic sensitivity pattern in acute tonsillitis. Int J Otorhinolaryngol Head Neck Surg. 4(5):1162-1166.
15. Khosravi, P., Rezvani, A. and Wiewiora, A., (2016). The impact of technology on older adults’ social isolation. Computers in Human Behavior, 63, pp.594-603.
16. Khalaf N.Z., (2020). Master Thesis on the Study of the Diagnostic and Molecular study of Streptococcus Pyogenes causing Pharyngitis in childhood of some region in Anbar Governorate. College of science. University of Anbar.
17. Ali H., Dhahi M. and Abd A. (2015). Molecular screening for erythromycin resistance genes in Streptococcus pyogenes isolated from Iraqi patients with tonsilo-pharyngites. African Journal of Biotechnology, 14(28): 2244-2250.
18. Richter, S.S., Heilmann, K.P., Beekmann, S.E., Miller, N.J., Miller, A.L., Rice, C.L., Doern, C.D., Reid, S.D. and Doern, G.V., (2005). Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clinical infectious diseases, 41(5), pp.599-608.
19. Dundar D., Sayan M. and Tamer G. (2010). Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients, Microbial Drug Resistance.16(4):279–284.
20. Hua, C.Z., Yu, H., Xu, H.M., Yang, L.H., Lin, A.W., Lyu, Q., Lu, H.P., Xu, Z.W., Gao, W., Chen, X.J. and Wang, C.Q., (2019). A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010–2017. BMC pediatrics, 19, pp.1-6.
21. Elsherif A.M., Abdelrahman Y.O., Mostafa A.H., Nahla M.E., (2011). Discrepancy between tonsillar surface and core culture in children with chronic tonsillitis and incidence of post tonsillectomy bacteraemia. AAMJ. 9: 171-182.
22. Camara M., Dieng A., and Boye C.S.B. (2013). Antibiotic susceptibility of Streptococcus pyogenes isolated from respiratory tract infections in dakar, senegal. Microbiology insights, 6. MBI-S12996.
23. Al Momani, W., Khatatbeh, M. and Altaany, Z., 2019. Antibiotic susceptibility of bacterial pathogens recovered from the hand and mobile phones of university students. Germs, 9(1), p.9.
24. Okonko, I.O., Soleye, F.A., Amusan, T.A., Ogun, A.A., Ogunnusi, T.A., Ejembi, J., Egun, O.C. and Onajobi, B.I.,( 2009). Incidence of multi-drug resistance (MDR) organisms in Abeokuta, Southwestern Nigeria. Global journal of pharmacology, 3(2), pp.69-80.
25. Al-Saimary I.E. (2011). Antibiogram and multidrug resistance patterns of Staph. aureus (MDRSA) associated with postoperative wound infections in Basra- Iraq. Med. Pract. Rev. 2 (6): 66-72.
26. Elander R.P., (2003). Industrial production of beta-lactam antibiotics. Appl Microbiol Biotechnol. 61(5-6):385-92.
27. Horcajada, J.P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N. and Grau, S., (2019). Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clinical microbiology reviews, 32(4), pp.e00031-
28. Buehrle, D.J., Shields, R.K., Shah, N., Shoff, C. and Sheridan, K., (2017). Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users. In Open forum infectious diseases (Vol. 4, No. 3). Oxford University Press.
Published
2023-06-08
How to Cite
Huda Refaat Ibraheem, & Ghaidaa Jihadi Mohammed. (2023). Prevalence of Multidrug Resistance in Streptococcus Pyogenes Isolates from Different Clinical Sources in Al-Diwaniyah City. Central Asian Journal of Medical and Natural Science, 4(3), 620-628. https://doi.org/10.17605/cajmns.v4i3.1572
Section
Articles